Revolution Medicines
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -4,702 | -3,802 | -205,749 | |
EBITDA | -348,254 | -289,440 | -260,912 | -237,044 |
EBIT | -352,956 | -293,778 | -264,714 | -240,760 |
Net Income | -364,892 | -305,206 | -247,787 | -213,416 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -276,163 | -210,660 | -229,207 | -197,701 |
Cash | 383,745 | 217,442 | 402,438 | 333,554 |
Basic Shares | 190,129 | 189,231 | 188,145 | 188,146 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $11,580 | $35,380 |
Gross Profit | -16,558 | -592,225 | 11,580 | 35,380 |
EBITDA | -1,090,512 | -677,700 | -477,876 | -248,623 |
EBIT | -1,107,070 | -689,524 | -487,185 | -258,279 |
Net Income | -1,131,301 | -600,093 | -436,367 | -248,705 |
Net Change In Cash | 0 | 0 | 11,580 | 35,380 |
Free Cash Flow | -913,731 | -567,744 | -358,301 | -235,217 |
Cash | 383,745 | 543,064 | 696,148 | 161,412 |
Basic Shares | 190,129 | 167,737 | 113,149 | 80,626 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$1.86 |
2025-09-30 | -$1.61 |
2025-06-30 | -$1.31 |
